After the US, two more clinical trials for treating coronavirus have started, one in in the Europe and another in China.
A European clinical trial involving some 3,200 people has been launched to test four possible experimental treatments against the coronavirus, according to news reports. The four treatments to be studied are remdesivir, lopinavir and ritonavir in combination, the latter being administered with or without interferon beta and hydroxychloroquine, French public health research body Inserm said in a statement.
The trials will be don on the patients now admitted in the hospitals with COVID and the subjects will be drawn from Belgium, Britain, France, Germany, Luxembourg, Spain and the Netherlands.
Similarly, China has also begun the first phase of a clinical trial for a novel coronavirus vaccine. It was launched on March 16, the same the US announced the trials.
The 108 participants, aged between 18 and 60, will be tested in three groups and given different dosages. They are all residents of the central city of Wuhan—where the new coronavirus first emerged late last year.
Apart from this, many other countries are also in the active race for developing a drug for the deadly virus which has killed over 14000 people across the world and still spreading fast without any effective treatment.
